It has been previously reported that the treatment with the anticancer drug Taxol, which polymerizes the cytoskeleton protein tubulin, may evoke cardiac arrhythmias reducing both the Nav1.5 expression at the plasma membrane and the Nav1.5 activation rate (Casini et al., 2010). Here, SCN5A is linked to cardiac rhythm disease.